There are many cancers and cancer cell lines that overexpress both EPHA2 and EFNA1, including bladder and ovarian cancer, which indicates that EFNA1 expression does not always lead to EPHA2 downregulation [24,25]. This evidence concerns the gene EFNA1 and ovarian cancer.